NCT04846816View on ClinicalTrials.gov

A Study to Assess Safety and Efficacy of a Novel Patch Infusor Device and Novel SUBCUTaneous Furosemide Formulation Combination in Patients With Heart Failure

PHASE1CompletedINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

May 6, 2021

Primary Completion Date

August 13, 2021

Study Completion Date

August 13, 2021

Conditions
Heart Failure
Interventions
COMBINATION_PRODUCT

SQIN-01

The drug and device combination is called SQIN-01. SQIN-01 is a combination of SQIN-Infusor and SQIN-Furosemide Investigational pump (SQIN-Infusor, medical device) intended for subcutaneous infusion of investigational product, SQINFurosemide.

Trial Locations (1)

G51 4TF

Queen Elizabeth University Hospital, NHS Greater Glasgow & Clyde, Glasgow

All Listed Sponsors
collaborator

University of Glasgow

OTHER

collaborator

NHS Greater Glasgow and Clyde

OTHER

lead

SQ Innovation, Inc.

INDUSTRY